Year: 2023
Type: review
Abstract: In low- and middle-income countries (LMICs), the fields of medicine and public health grapple with numerous challenges that continue to hinder patients' access to healthcare services. ChatGPT, a publicly accessible chatbot, has emerged as a potential tool in aiding public health efforts in LMICs. This viewpoint details the potential benefits of employing ChatGPT in LMICs to improve medicine and public health encompassing a broad spectrum of domains ranging from health literacy, screening, triaging, remote healthcare support, mental health support, multilingual capabilities, healthcare communication and documentation, medical training and education, and support for healthcare professionals. Additionally, we also share potential concerns and limitations associated with the use of ChatGPT and provide a balanced discussion on the opportunities and challenges of using ChatGPT in LMICs.
Institutions: Beihang University, University of Michigan, Michigan Medicine, University of Health Science, Hanoi Medical University, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Ludwig Boltzmann Institute Digital Health and Patient Safety, Medical University of Vienna, Tsinghua University, Duke University, Nanyang Technological University, Imperial College London, Beijing Tongren Hospital, Capital Medical University, Singapore National Eye Center, Singapore Eye Research Institute, Beijing Tsinghua Chang Gung Hospital, National University of Singapore, Duke-NUS Medical School
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,680
Funder: National Institutes of Health
OpenAlex ID: W4386776067
